When you hear kidney cancer statistics, it’s natural to wonder how much age affects survival. Research shows that older age is often linked to lower survival, especially in renal cell carcinoma (RCC), the most common type.
However, age is just one factor among many. Some large cancer databases use age-adjusted statistics, which can make it harder to understand how age alone affects survival.
If you’re looking at kidney cancer survival by age, it’s important to understand what each statistic means. Some combine all kidney and renal pelvis cancers, while other data focuses only on RCC or clear cell RCC, the most common subtype. Survival may be reported as five-year relative survival, 10-year net survival, or cancer-specific survival.
Those differences can affect how you interpret the numbers. Here’s what we know about kidney cancer survival rates by age.
Age is one factor doctors consider when talking about prognosis, or the likely course of a disease. However, it’s not the only factor and often not the most important. Stage — how far the cancer has spread — is one of the strongest predictors of kidney cancer outcomes.
Other factors include the type of kidney cancer, tumor size and grade, tumor location, and any lymph node involvement. Cancer Research UK notes that survival rates are based on many factors and reflect large groups of people, not individuals. This means two people of the same age can have very different outcomes depending on cancer stage and cancer cell details, as well as their general health and response to treatment.
It can be hard to find kidney cancer survival rates because many cancer organizations use a method known as age adjustment or age standardization. This approach lets researchers compare cancer rates across populations by accounting for differences in how ages are grouped.
According to the World Cancer Research Fund, an age-standardized rate shows what the rate would be if the population had a standard age structure. The National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program uses age-adjusted rates for many kidney and renal pelvis cancer statistics, including incidence and death rates.
Age adjustment is useful for comparing trends over time or between groups, but it doesn’t show outcomes for specific age groups. Although survival by age — such as comparing age 40 to 75 — can be calculated, public sources such as SEER and the American Cancer Society more often report kidney cancer survival by stage rather than by age.
There are several types of kidney cancer. RCC makes up about 9 out of 10 cases. Within RCC, clear cell RCC accounts for about 70 percent of cases.
Because of this, many studies on age and prognosis focus on RCC overall or just on clear cell RCC. When you read about survival rates for RCC or clear cell RCC, those findings may not apply the same way to other, less common types of kidney cancer.
Some studies do report kidney cancer survival rates by age, even though many large databases don’t break the data down this way.
A widely cited 2018 study used SEER data from the United States to look at kidney cancer survival by age. This study included multiple kidney cancer types and reported eight-year cancer-specific survival, which means deaths counted were only from kidney cancer. In this study, eight-year cancer-specific survival was:
The study also found that older age was linked to lower survival, even after accounting for other factors.
The same study found that survival differences by age were more noticeable in localized-stage disease than in regional or distant-stage disease. In other words, age seemed to have a stronger effect when kidney cancer was found early and less effect when the cancer was more advanced at diagnosis.
A 2022 study focused on clear cell RCC using SEER data from 58,372 people. The researchers reported that younger age was linked to better survival and that tumor stage tended to increase with age.
This study didn’t provide a simple chart of survival rates by age, but it showed a clear pattern: As age increased, both overall survival and cancer-specific survival decreased. The researchers identified age cutoffs of 51 and 76 years and concluded that prognosis differed across age groups.
Together, these studies suggest that older age is linked to poorer prognosis in RCC, especially clear cell RCC. However, this doesn’t mean that every older person will have a worse outcome or that age matters more than stage or other factors.
If you’re searching for stage 4 kidney cancer survival rates by age, there’s not as much publicly available data. Most major sources report survival by stage and age separately, not together. For example, the American Cancer Society reports U.S. five-year relative survival for kidney and renal pelvis cancers diagnosed (2015 to 2021) as:
Relative survival compares people with the same type and stage of cancer with people in the general population.
Cancer Research UK reports five-year net survival in England for kidney cancer diagnosed from 2016 to 2020 as about 90 percent for stage 1, 75 percent for stages 2 and 3, and 15 percent for stage 4. Net survival adjusts for the fact that some people would have died from other causes.
These numbers show that cancer stage plays a major role in survival. Even though older age is linked to lower survival overall, a younger person with stage 4 disease may have a more serious outlook than an older person with early-stage disease.
Long-term kidney cancer survival rates are reported less often than five-year rates. Cancer Research UK provides 10-year survival by age for kidney cancer in the United Kingdom, showing differences by age and sex. They report 10-year survival as:
Those are some of the clearest available data on kidney cancer survival by age. Keep in mind that these numbers reflect kidney cancer overall in the U.K., across all types and stages.
Overall, research shows that older age is often linked to lower kidney cancer survival, especially in RCC and clear cell RCC. However, age is just one factor. Stage, grade, subtype, lymph node involvement, spread to other organs, and your overall health all play a role in prognosis.
Statistics can help show trends in large groups, but they don’t predict what will happen for one person. They summarize data from many people and can give a general idea of outcomes. To better understand your personal risk factors and prognosis, talk with your kidney cancer specialist.
On MyKidneyCancerTeam, people share their experiences with kidney cancer, get advice, and find support from others who understand.
Have you discussed prognosis with your cancer care team? Let others know in the comments below.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.